Supportive Care in Cancer

, Volume 14, Issue 3, pp 260–267

Complementary and alternative medicine use in breast cancer patients in Europe

  • Alexander Molassiotis
  • Julia A. Scott
  • Nora Kearney
  • Dorit Pud
  • Miriam Magri
  • Sarka Selvekerova
  • Ingrid Bruyns
  • Paz Fernadez-Ortega
  • Vassiliki Panteli
  • Anita Margulies
  • Gudbjorg Gudmundsdottir
  • Ljiljana Milovics
  • Gulten Ozden
  • Nurgun Platin
  • Elisabeth Patiraki
Original Article

DOI: 10.1007/s00520-005-0883-7

Cite this article as:
Molassiotis, A., Scott, J.A., Kearney, N. et al. Support Care Cancer (2006) 14: 260. doi:10.1007/s00520-005-0883-7

Abstract

Complementary and alternative medicine (CAM) has gained popularity among cancer patients in the past years. For this study, CAM includes any group of health care systems, practices or products that are not considered to be part of conventional medicine at present (National Center for Complementary and Alternative Medicine). The present study assessed patterns of CAM use in breast cancer patients in Europe. The study used a descriptive cross-sectional design, and data were collected through a 27-item questionnaire. The sample, which was part of a larger study, consisted of 282 breast cancer patients from 11 countries in Europe. Among participants, 44.7% used CAM since their diagnosis of cancer. The most common therapies used included herbal medicine (46.4%) and medicinal teas, relaxation techniques, spiritual therapies, homeopathy and vitamins/minerals. Younger patients with higher education and who had received combination treatments for their cancer in the past were more likely to use CAM. High levels of satisfaction were reported, with only 6.5% of the women reporting no benefits from the CAM used. Main sources of information about CAM were mostly friends/family and the media. Findings suggested that a high proportion of breast cancer patients used CAM, which may have implications for the clinical management of these patients.

Keywords

Complementary medicine Alternative medicine Complementary therapies Breast cancer Europe 

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Alexander Molassiotis
    • 1
  • Julia A. Scott
    • 2
  • Nora Kearney
    • 2
  • Dorit Pud
    • 3
  • Miriam Magri
    • 4
  • Sarka Selvekerova
    • 5
  • Ingrid Bruyns
    • 6
  • Paz Fernadez-Ortega
    • 7
  • Vassiliki Panteli
    • 8
  • Anita Margulies
    • 9
  • Gudbjorg Gudmundsdottir
    • 10
  • Ljiljana Milovics
    • 11
  • Gulten Ozden
    • 12
  • Nurgun Platin
    • 13
  • Elisabeth Patiraki
    • 8
  1. 1.School of NursingUniversity of ManchesterManchesterUK
  2. 2.Department of Nursing and MidwiferyUniversity of StirlingStirlingUK
  3. 3.Faculty of Social Welfare and Health StudiesUniversity of HaifaHaifaIsrael
  4. 4.Istituto Nazionale TumoriUniversità degli Studi di MilanoMilanItaly
  5. 5.Masaryk Memorial Cancer InstituteBrnoCzech Republic
  6. 6.Belgian Society of Oncology NursingBrusselsBelgium
  7. 7.Institut Català Oncologia ICOBarcelonaSpain
  8. 8.Greek Oncology Nursing SocietyAthensGreece
  9. 9.Klinik und Poliklinik für OnkologieUniversity Hospital ZürichZurichSwitzerland
  10. 10.Department of OncologyLandspitaliReykjavikIceland
  11. 11.Department of EducationInstitute for Oncology and RadiologyBelgradeSerbia and Montenegro
  12. 12.Gazi University HospitalAnkaraTurkey
  13. 13.School of Health SciencesKoc UniversityIstanbulTurkey

Personalised recommendations